Karyopharm Therapeutics
Massachusetts, --
--
Healthcare
•AI
•Startup
Senior Medical Science Liaison, New York City & Northern NJ
Remote, Oregon, --
Full-time
Description
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). Karyopharm's lead compound, XPOVIO® (selinexor), received...
Financials
Type
public
Annual Revenue
--
Market Cap
--
Subscribe to Refer Me premium to get referred to this role at Karyopharm Therapeutics!
